Stryker (SYK) Cash from Investing Activities (2009 - 2026)
Stryker (SYK) reported Cash from Investing Activities of -$185.0 million for Q1 2026, up 95.53% year-over-year from -$94.6 million in Q1 2025, and up 39.34% quarter-over-quarter from -$305.0 million in Q4 2025.
Stryker (SYK) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Cash from Investing Activities data on file, last reported at -$185.0 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$185.0 million, up 95.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$915.0 million (up 86.4% YoY), and the FY2025 annual result was -$4.9 billion, down 62.2% from the prior year.
- Cash from Investing Activities rose to -$185.0 million in Q1 2026 per SYK's latest filing, from -$305.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $72.0 million in Q3 2022 and troughed at -$4.1 billion in Q1 2025.
- A 5-year average of -$702.2 million and a median of -$185.0 million in 2026 frame the typical range for Cash from Investing Activities.
- On a YoY basis, Cash from Investing Activities climbed as much as 129.15% in 2022 and fell as far as 2693.75% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$162.0 million in 2022, then climbed by 6.17% to -$152.0 million in 2023, then tumbled by 99.34% to -$303.0 million in 2024, then decreased by 0.66% to -$305.0 million in 2025, then surged by 39.34% to -$185.0 million in 2026.
- Business Quant data shows SYK's Cash from Investing Activities at -$185.0 million in Q1 2026, -$305.0 million in Q4 2025, and -$321.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -159.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -185.00 Mn |
| Mar 31, 2026 | -185.00 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Sep 30, 2025 | -321.00 Mn |
| Sep 30, 2025 | -321.00 Mn |
| Jun 30, 2025 | -104.00 Mn |
| Jun 30, 2025 | -104.00 Mn |
| Mar 31, 2025 | -4.14 Bn |
| Mar 31, 2025 | -4.14 Bn |
| Dec 31, 2024 | -303.00 Mn |
| Dec 31, 2024 | -303.00 Mn |
| Sep 30, 2024 | -2.17 Bn |
| Sep 30, 2024 | -2.17 Bn |
| Jun 30, 2024 | -117.00 Mn |
| Jun 30, 2024 | -117.00 Mn |
| Mar 31, 2024 | -408.00 Mn |
| Mar 31, 2024 | -408.00 Mn |
| Dec 31, 2023 | -152.00 Mn |
| Dec 31, 2023 | -152.00 Mn |